7 results
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... Risk Factors for Severe ... Respiratory Cardiac Hematologic ... #criticalcare # ... NonIntensivist #diagnosis #management
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
: • Cytokine Release ... organ dysfuxtion, ICU ... overload, PCC to reverse ... APML #diagnosis #management ... #hematology #oncology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
Over-anticoagulation can lead to severe ... #management #algorithm ... #pharmacology # ... #decisionaid #cardiology ... #hematology #warfarin
Checklist for Treatment of Delirium in the ICU 

Remove causative factors 
 - 
Exclude hypoglycemia if
Delirium in the ICU ... sleeping, administer pharmacologic ... Delirium #Checklist #Management ... #Treatment #MICU ... #CriticalCare
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
differential #algorithm #management ... #cardiology #treatment ... heartfailure #chf #criticalcare ... #icu #clinical ... #pharmacology
Management of Immune Checkpoint Inhibitor (ICI) Induced Cardiotoxicity
Problem - Immune checkpoint inhibitors (ICIs) are associated with
Management of Immune ... interventions MANAGEMENT ... heart failure management ... Cardiotoxicity #cardiology ... #oncology #management
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
Management of Anthracyclines ... infarction, moderate to severe ... Cardiotoxicity #cardiology ... #oncology #pharmacology